Table of Contents
Cross-Gene's "Black or White" is one of those K-pop tracks that most non-Korean fans have never heard, but that anyone inside the K-content industry recognizes as a case study. Released on February 8, 2017 as the title track of the six-member group's fourth mini album "Mirror," it was a bloody, mental-health-themed music video from a mid-tier second-generation act that most casual K-pop coverage had already written off. What most fan blogs missed was the survival math behind it. This piece breaks down why "Black or White" worked as a creative bet, why the Cross-Gene (크로스진) multinational template later got copied by SM Entertainment's NCT, and why Amuse Korea's decade-long failure to scale the group tells you something important about how few K-pop nano-labels ever make it to year 10. After more than a decade of watching this space from inside the Korean entertainment industry, this is the read on a group that history has almost forgotten.
Black Unit, White Unit, and the mirror thesis behind the song
Structurally, "Black or White" is not one song. It is three. The "Mirror" mini album ships "Black Mind," "White Mind," and the title track "Black or White," engineered as a mirror pair with a shared bridge running through all three. Amuse Korea split the six-member lineup into two subunits for the pre-releases. The Black Unit (Seyoung, Takuya, Casper) recorded "Black Mind," a paranoid, trust-nobody track built around a partner who cannot open up. The White Unit (Shin Wonho, Sangmin, Yongseok) recorded "White Mind," a blindly-loving track where the main character ignores every red flag their partner throws up. Then the title track lifts the "White Mind" chorus, layers it over the "Black Mind" verses and instrumental, and glues everything with a bridge shared across all three cuts. Play "Black Mind" and "White Mind" at the same time and you get chaos, which is the point. The listening thesis is that neither extreme resolves without borrowing from the other.
This is the kind of structural gimmick that Amuse Korea should not have been able to pull off with a mid-tier act in 2017. Splitting a six-member group into two three-member subunits, releasing two pre-release singles that are essentially demo-tier B-sides, then dropping a title track that only makes musical sense if you have already heard both pre-releases, is what SM Entertainment would do with EXO-K and EXO-M or (later) NCT sub-units. That Amuse tried the same maneuver with a group whose Korean album sales sat somewhere in the 10,000 to 20,000 physical copies per release range is either brave or delusional. In hindsight, it is what makes "Black or White" the most interesting track in the Cross-Gene catalog, because it is the moment the group stopped chasing a generic idol lane and started leaning into concept-driven storytelling that would have fit an EXO-tier budget.
Why the 19-rated bloody MV was a strategic bet, not just edgelord posturing
The "Black or White" music video is rated 19+ in Korea, which for a K-pop MV is unusual and financially painful. It cuts you off from music show performances (the choreography has to be watered down), blocks daytime broadcast, and eats into ad revenue. So why did Amuse Korea let a mid-tier group ship an MV where members get killed by their own evil doubles and Sangmin appears in a coffin? Because in 2017, second-generation groups without a top-3 label behind them had roughly two options. Chase the same trendy Korean chart formula that BIGBANG, BEAST, and INFINITE were already winning at (and lose), or bet on a distinct concept that could travel to Japanese and Chinese fandoms who prioritize story-driven fan engagement over Melon chart wins.
The mental health framing is what makes the concept smart. 우울증 (depression) is still socially stigmatized in Korea in a way most Western fans do not fully grasp. Framing internal darkness as literal violent clones killing the good version of yourself, then reviving the innocent version after the shared bridge, is the sort of visual metaphor that gets you fan-cafe post-length reactions rather than one-time streams. That is what a nano-label needs. A mid-tier idol group cannot win on radio play. It wins on 팬덤 (fandom) depth: fans who buy multiple album versions, attend fan meetings in Singapore and Tokyo, and stick with the group through slower comebacks. The 19-rated blood was not the point. It was the delivery vehicle for a concept that would keep the existing Cross-Gene fanbase deeply engaged. Whether that math actually worked long-term is a separate question, and we will get to it.
Cross-Gene as the pre-NCT multinational template
Rewind five years. Cross-Gene debuted on June 11, 2012 with the mini album "Timeless: Begins," and it was the first K-pop idol group with a fully Japanese member from day one. Terada Takuya, who had been signed to Amuse in Japan since 2010, transferred to Amuse Korea and became the industry's first true J-national K-pop idol. Alongside him were two Chinese members (Casper and JG initially) and three Korean members. Six people, three nationalities, one boy group. The pitch, as Amuse Korea put it publicly at the time, was that they would "cross the superior genes of each country to create one perfect group." The group name literally comes from that thesis.
In 2012 this was actually a novel structural bet. Multinational K-pop had been tried before (Miss A had Fei and Jia, Super Junior-M had Han Geng, f(x) had Amber and Victoria), but Cross-Gene was the first group where 다국적 그룹 (multinational group) status was the entire brand rather than a fluke of casting. And this is where it gets industry-relevant: NCT, which SM Entertainment launched in 2016, essentially took the Cross-Gene multinational thesis and made two structural upgrades. First, a sub-unit system (NCT U, NCT 127, NCT Dream, WayV) so members could be re-shuffled by market rather than locked into one fixed lineup. Second, an infinitely expandable roster, so new nationalities could be added over time without disbanding anyone. Cross-Gene had neither. Its one-fixed-lineup approach dated fast the moment SM shipped NCT U's "The 7th Sense" in April 2016.
Amuse Korea's J-pop-first playbook that most Western fans miss
Cross-Gene's parent company is Amuse Inc., one of Japan's biggest talent agencies (they manage Southern All Stars, Perfume, and Babymetal). Amuse Korea, the subsidiary that debuted Cross-Gene, was set up specifically to build an idol act that could work Japan and Korea in parallel, with Japan positioned as the primary revenue base. This is the reverse of the usual K-pop template, where groups debut in Korea, chart on Melon, then use that as a launchpad for Japan and Southeast Asia. Cross-Gene's release schedule reflected the flip. Multiple Japanese single releases per year, regular Zepp DiverCity live shows, Tokyo fan meets, and lighter Korean promotions timed just to keep the group alive in the Korean idol conversation.
This is why casual K-pop fans in the US often heard nothing about Cross-Gene between comebacks. They were probably filming a Japan-only reality show, on a Zepp tour, or shooting Japanese single covers. Amuse understood something a lot of Korean labels took another five years to figure out. J-pop fans buy meaningfully more physical merchandise per person than Korean fans do, and a mid-tier group can survive on Japan sales alone if the fandom is deep enough. The catch is that surviving on Japan sales alone caps your ceiling. You will not build the kind of global TikTok moment that would let you scale into a top-tier act. And by the mid-2010s, that ceiling was starting to matter, because BTS proved that the ceiling was no longer domestic Korea plus Japan. It was every country with a smartphone.
What NCT copied, what nano-labels cannot copy, and why Cross-Gene stalled
Watch NCT's rollout from 2016 to 2020 and you can see the Cross-Gene DNA in the multinational thesis, but with SM's structural upgrades bolted on. Sub-units let SM run NCT 127 in Korea, NCT Dream in Korea and Southeast Asia, and WayV in the Chinese market (Mandarin releases under Label V) simultaneously. Cross-Gene tried to be one act in three markets. NCT became different acts in each market, sharing a brand. That is a fundamentally more scalable structure, and it is why by 2019 NCT was doing world tours while Cross-Gene was quietly losing members. Casper left in September 2017, Takuya announced his departure from Amuse Korea in December 2018, Seyoung followed later, and the group's last Korean release was in 2018. 활동 중단 (activity suspension) was never formally called, but by 2021 Cross-Gene was effectively disbanded.
The nano-label problem is what killed the scaling. Amuse Korea only had one idol group in its idol division. When one group is your entire idol business, you cannot cross-subsidize a bad year with revenue from another act, cannot re-cast members between groups the way HYBE quietly moves trainees between BTS-adjacent projects, and cannot fund a proper training pipeline because you cannot afford dorms, vocal coaches, and choreographers for 40 to 50 trainees at once. This is the structural reason nano-labels rarely survive 10 years in K-pop. Big Hit Entertainment (now HYBE) was the outlier, not the template. For every Big Hit that broke through with BTS, there are 20 Amuse Koreas and Stardom Entertainments and Chrome Entertainments and IST Entertainments that either scaled down, got absorbed, or quietly went dormant. The K-pop hit rate is closer to venture capital than to major-label pop.
February 2026 brought a small twist. Shin Wonho and Yongseok announced they would return as a Cross-Gene duo under Amuse Korea, starting with Shin's 15th anniversary concert on March 27. It is not a full reunion (Casper, Takuya, Seyoung, and Sangmin are all out), and the 활동 중단 that defined Cross-Gene's last eight years technically becomes a two-member reboot rather than a real comeback. But for fans who lived through the "Black or White" era, it is a reminder that some second-generation groups just refuse to fully vanish, even when the industry math has long since moved past them. That is the appeal point most K-pop trend pieces miss. The economics fail, but the emotional contract between a mid-tier group and its 팬덤 does not have to.
Why Cross-Gene still matters as an industry case study
The Cross-Gene story is not a rags-to-riches K-pop success. It is the opposite. It is a well-designed multinational bet that Amuse Korea did not have the label infrastructure to scale, and a "Black or White" concept album that showed the group could out-punch its budget on creative but not on distribution. If you are trying to understand why K-pop consolidated so violently in the mid-2010s (why HYBE, SM, JYP, and YG took over the top of the market while dozens of nano-labels went dormant), Cross-Gene is one of the cleanest case studies from the 2세대 K-pop (2nd generation K-pop) era. And if you are trying to spot the next KATSEYE or WayV style multinational bet in 2027 and 2028, the lesson from Cross-Gene is that the multinational thesis alone will not carry you. You also need sub-units, expansion capacity, and a parent company with room to lose money for three album cycles while a new market builds. Cross-Gene had the first idea. It did not have the rest.
Explore Korea with Daebak
Bring a little of Korea into your home every month with the Daebak Box, hand-picked K-culture snacks, K-pop merch, and lifestyle finds delivered straight from Seoul to your door.
